Cancer Letters 2013-08-19

Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NFκB dependent manner.

Deobrat Dixit, Ruchi Ghildiyal, Nikhil Ponnor Anto, Sourav Ghosh, Vivek Sharma, Ellora Sen

Index: Cancer Lett. 336(2) , 347-58, (2013)

Full Text: HTML

Abstract

Since Shh pathway effector, Gli1, is overexpressed in gliomas, we investigated the effect of novel Shh inhibitor SANT-1 on glioma cell viability. Though SANT-1 failed to induce apoptosis, it reduced proliferation of glioma stem-like cells. Apart from canonical Shh cascade, Gli1 is also induced by non-canonical pathways including NFκB. Therefore, a combinatorial strategy with Ras/NFκB inhibitor, Guggulsterone, was employed to enhance effectiveness of SANT-1. Guggulsterone inhibited Ras and NFκB activity and sensitized cells to SANT-1 induced apoptosis via intrinsic apoptotic mechanism. Inhibition of either Ras or NFκB activity was sufficient to sensitize cells to SANT-1. Guggulsterone induced ERK activation also contributed to Caspase-9 activation. Since SANT-1 and Guggulsterone differentially target stem-like and non-stem glioma cells respectively, this combination warrants investigation as an effective anti-glioma therapy. Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.


Related Compounds

Related Articles:

Smoothened adopts multiple active and inactive conformations capable of trafficking to the primary cilium.

2009-01-01

[PLoS ONE 4(4) , e5182, (2009)]

MicroRNA-602 and microRNA-608 regulate sonic hedgehog expression via target sites in the coding region in human chondrocytes.

2015-02-01

[Arthritis Rheumatology 67(2) , 423-34, (2015)]

MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.

2015-05-01

[FASEB J. 29 , 1817-29, (2015)]

Ciliary IFT80 balances canonical versus non-canonical hedgehog signalling for osteoblast differentiation.

2016-01-01

[Nat. Commun. 7 , 11024, (2016)]

Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway.

2015-03-01

[Mol. Cancer Ther. 14 , 727-39, (2015)]

More Articles...